Kazia Therapeutics (KZIA) EBITDA Margin (2011 - 2017)
Kazia Therapeutics (KZIA) posted EBITDA Margin of 123.34% for Q2 2017, up 58.15% on a QoQ basis from 294.7% in Q4 2016, and up 17523.0% year-over-year from N/an in Q2 2016.
Kazia Therapeutics (KZIA) EBITDA Margin (2011 - 2017) Analysis & Trends
Kazia Therapeutics' EBITDA Margin history runs 6 years deep, the most recent figure standing at 123.34% for Q2 2017.
- Quarterly EBITDA Margin rose 17523.0% year-over-year to 123.34% in Q2 2017, while the trailing twelve-month figure through Jun 2017 was 213.43% (up 2329.0% YoY) and the FY2025 annual result came in at 53447.62%, down 5228705.0% from the prior year.
- EBITDA Margin was 123.34% for Q2 2017 at Kazia Therapeutics, up from 294.7% in the prior quarter.
- Across five years, EBITDA Margin topped out at 53.62% in Q4 2013 and bottomed at 298.58% in Q2 2016.
- A 4-year average of 205.46% and a median of 257.07% in 2015 frame the typical range for EBITDA Margin.
- Annual changes were most pronounced in 2016 — EBITDA Margin sank 3763 bps — and 2017, when it jumped 17523 bps.
- Kazia Therapeutics' EBITDA Margin stood at 53.62% in 2013, then slumped by 379 bps to 257.07% in 2015, then retreated by 15 bps to 294.7% in 2016, then soared by 58 bps to 123.34% in 2017.
- Business Quant data shows KZIA's EBITDA Margin at 123.34% in Q2 2017, 294.7% in Q4 2016, and 298.58% in Q2 2016.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 16.51% |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 38.10% |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 17.83% |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 31.68% |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Kazia Therapeutics | 4.11 Mn | 4.11 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2017 | -123.34% |
| Dec 31, 2016 | -294.70% |
| Jun 30, 2016 | -298.58% |
| Dec 31, 2015 | -257.07% |
| Dec 31, 2013 | -53.62% |
| Dec 31, 2012 | -61.99% |
| Dec 31, 2011 | 1,197.30% |